The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Yumanity Therapeutics Inc(NASDAQ:YMTX)


Yumanity Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company is headquartered in Boston, Massachusetts.
Founded: 2014
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Share this website to your friends
Yumanity Therapeutics Op Cashflow Per Share ttm
Yumanity Therapeutics Free Cashflow Per Share ttm
Yumanity Therapeutics Cash Per Share ttm
Yumanity Therapeutics P/S ratio ttm
Yumanity Therapeutics (GAAP) P/E ratio ttm
Yumanity Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.